Theirs, in our words
#51at 91%●●○○○2× p · 20 words
The FAQ heading, phrased as questions the brand encouraged her to ask, and a sub-line: the brand knows she has been burned before and offers to be honest about itself.
Why it works. Frame the questions as candour. candorvindicationmirroring
Why it sits here, and how it is written
The FAQ opens at 91% and holds 39% of the page's words in 7% of its height, so the answers sit in closed accordions. The heading recasts objections as questions the seller welcomes, in keeping with reason seven.
The burned-before line returns from entry 27; a second use weakens the first.
Planned for ours, before we wrote: kept the move. An FAQ framed as straight answers. Our PDP section is already named for honest answers.
See these lines on their page ↗#52at 92%●●○○○p · fine · 97 words
Question: why is it new to her. The answer retells reason four at length (fish farms took the supply for thirty years), adds Japanese researchers publishing human trials from the early 2000s, and hints that the silence was deliberate.
Why it works. Answer the unfamiliarity objection for the reader who skipped the list. objection-preemptreason-whycommon-enemy
Why it sits here, and how it is written
The first two questions are reasons four and five again, for the reader who jumped past the list to the card. The FAQ is a second, compressed copy of the argument and begins with the two objections.
It repeats reason four almost sentence for sentence (vendor point 020). The closing hint that the gap was deliberate is an insinuation with nothing behind it.
Planned for ours, before we wrote: rewritten to our claims. Answer from p7 in two sentences. No supply-conspiracy hint. p7
See these lines on their page ↗#53at 93%●●●○○p · fine · 92 words
Question: an earlier try that did nothing. The answer blames dose and source and clears the molecule: most products are 4 mg synthetic from petroleum, the trials used 12 mg from microalgae, and an underdosed bottle tested an imitation.
Why it works. Answer the it-failed objection for the reader who skipped the list. vindicationobjection-preemptcontrast
Why it sits here, and how it is written
It is reason five again, placed second, so the two objections that opened the second half of the list also open the FAQ.
The last sentence, separating the molecule from a cheap copy of it, is the sharpest line in the FAQ. The remainder duplicates the list.
Planned for ours, before we wrote: rewritten to our claims. b7 (12 mg against 4 to 6 mg), r16 (synthetic is petrochemical; ours is not), c1 (the category's failure rate). Said once on our page, not twice. b7r16c1
See these lines on their page ↗#54at 93%●○○○○p · fine · 18 words
Question: why dose matters and how this differs from marketplace products. The answer is the page editor's two-word placeholder; it was never written.
Why it works. None: the answer is missing.
Why it sits here, and how it is written
The question restates the page's central argument, which makes the missing answer the most exposed gap on the page. It has presumably survived because the accordion is closed by default.
A software default left live (vendor point 012). Any reader who opens it learns how the page was assembled.
Planned for ours, before we wrote: rewritten to our claims. If we ask the dose question we answer it: b7, with the trial dose cited from the paper (b1). b7b1
See these lines on their page ↗#55at 94%●●●○○p · fine · 91 words
Question: softgel against cream. Answer: creams work at the surface; the damage sits within the membrane of the cell; a fat-soluble molecule swallowed with fat reaches skin cells through the blood. A 2012 paper (Tominaga) is cited for oral use.
Why it works. Justify swallowing something for a skin problem. reason-whycontrastborrowed-authority
Why it sits here, and how it is written
This reader's habit is topical, and the format itself needs defending. The question is held back to the FAQ because the list made the same point by geometry in reason two; here it is restated for the literal-minded.
Clear cause and effect in four steps. The carrier named here is coconut oil; in entry 21 it is MCT oil. A second paper from the same author appears, dated 2012, which the list never mentioned.
Planned for ours, before we wrote: rewritten to our claims. From within: it spans the membrane (m2) and restores the small-vessel flow that carries nutrients to skin (m5). Her creams stay; the softgel works where they do not reach (p3). No carrier-oil claim (b8 is banned); with a meal that has some fat (r31). m2m5p3r31
See these lines on their page ↗#56at 94%●●●○○p · fine · 117 words
Question: how soon. The answer reprints the four-step roadmap (weeks 1, 4, 6 and 8-plus) nearly unchanged, adds that results vary, and asks her to hold her verdict until she has taken the full dose for the full time.
Why it works. Repeat the timeline and ask for patience. future-pacingcandorcommitment
Why it sits here, and how it is written
It repeats the roadmap of entries 40 to 43 for the reader who met the FAQ first. Its new final sentence is the real message: judge only after the full dose for the full time, which carries her to the edge of the guarantee window.
At 111 words the longest answer on the page, and four fifths of it is a reprint (vendor point 020). The results-vary clause is the only hedge of its kind on the page.
Planned for ours, before we wrote: rewritten to our claims. One timeline, stated once on the page, from the trial record (b1); early sign from b6 if used. b1b6
See these lines on their page ↗#57at 95%●●●●○p · fine · 78 words
Question: what if nothing happens. The answer: a refund, unconditional, with no forms and nothing to post back; then a jab at brands that hide behind hard returns and do not believe in their product.
Why it works. Restate the guarantee as proof of confidence. risk-reversalcandorcommon-enemycontrast
Why it sits here, and how it is written
The refund question comes straight after the timeline because a reader told to wait eight weeks next asks what happens if the wait was for nothing. The guarantee is argued as evidence of belief, not only as insurance.
The answer ends on the page's shortest sentence, two words, which lands. The three refusals are concrete and checkable.
Planned for ours, before we wrote: our offer in its place. 30-Day Money-Back Guarantee: full refund, she keeps the bag. We state our terms and make no remark about other brands' returns.
See these lines on their page ↗#58at 95%●●●○○p · fine · 60 words
Question: is it tested by a third-party lab. The answer: yes, each batch, independently, for purity, potency, contaminants and heavy metals; a certificate can be requested; dose and source are said to match the published trials.
Why it works. Answer the quality question. objection-preemptspecificityborrowed-authority
Why it sits here, and how it is written
Testing comes after the refund question: once the money is safe, she asks whether the product is. It repeats reason seven's claims for the reader who skipped the list.
Here the certificate can be requested; in entry 27 it is published with every product. One of the two is wrong, and a reader who opens this answer after reading reason seven will notice.
Planned for ours, before we wrote: our proof in its place. c3 worded as third-party lab tested, with results published per batch once the first certificate exists; c5 for purity (no heavy metals, no environmental contaminants); c4 for the source. c3c5c4
See these lines on their page ↗#59at 96%●●●○○p · fine · 77 words
Question: is daily use safe. The answer: yes, studied at 6 to 12 mg without notable side effects; above 16 mg some report orange-tinted urine, called harmless; pregnant or nursing women and anyone on prescriptions should consult a doctor.
Why it works. Answer the safety question with a range and a caveat. objection-preemptcandorspecificityborrowed-authority
Why it sits here, and how it is written
Safety is the eighth question, among the late, careful ones. A reader this far down is reading the label, and the answer treats her as someone who does.
Volunteering a side effect at a higher dose is candour that buys belief for the dose being sold. The doctor caveat is standard and well placed at the end.
Planned for ours, before we wrote: kept the move. r27 (allergen and age safety) and r28 (medication, with the blood-thinner caution). We do not quote side-effect thresholds the gate does not hold. r27r28
See these lines on their page ↗#60at 96%●●○○○p · fine · 70 words
Question: what if she has health concerns. The answer: see her doctor, above all if she takes anticoagulants, immune-suppressing drugs or hormones; the safety record is called strong; she is invited to email and promised candour, not selling.
Why it works. Defer to her doctor and offer a human contact. candorobjection-preemptrisk-reversal
Why it sits here, and how it is written
It overlaps the safety question before it and exists for its last sentence: an invitation to write in. For a wary buyer an address to write to is itself proof that someone is there.
The deference to her doctor's fuller knowledge of her is respectful without being timid. Nearly a duplicate of the previous question.
Planned for ours, before we wrote: kept the move. r28, including the blood-thinner caution, and our support address. One safety question, not two. r28
See these lines on their page ↗#61at 97%●●●○○p · fine · 91 words
Question: perimenopause or HRT. The answer: hormone shifts are said to speed oxidative stress and collagen loss; the product was built for that window; it is no hormone and is said not to interfere with HRT; ask the doctor.
Why it works. Speak to the life stage by name. identificationmirroringobjection-preemptcandor
Why it sits here, and how it is written
Perimenopause was planted as a clause in reason one and voiced in the last comment; only here, second to last in the FAQ, is it addressed head on. The page's most specific audience marker is kept in the least-read place, where it cannot narrow the headline's reach.
The claim that the product was built for this window is positioning with nothing on the page to support it. The no-interference statement is a medical assertion made flatly.
Planned for ours, before we wrote: rewritten to our claims. The gate holds no perimenopause or HRT claim. The nearest id is r12, a pillar claim and not a skin one. Our answer is r28: talk to her doctor. If the life stage is to be addressed it needs its own gate entry first. r28
See these lines on their page ↗#62at 97%●●○○○p · fine · 65 words
Question: will it stain teeth or turn skin orange. The answer: no; above 16 mg a faint orange colouring of urine is reported, rarely at 12 mg; the colour stays inside the body.
Why it works. Remove a cosmetic worry about a red pigment. objection-preemptcandorspecificity
Why it sits here, and how it is written
The last question is the smallest worry, and an odd one to end on. It also shows the distance between the two pages: here skin colour from the softgel is a fear to be denied, while the Rovina page sells it as the headline benefit.
Repeats the urine detail of entry 59. A flat denial first, then the detail.
Planned for ours, before we wrote: kept the move. Fair to answer if asked; r27 covers safety. We promise no colour change to skin in either direction; the glow (b5) is shown in pictures. r27b5
See these lines on their page ↗